Compare Marriott International Inc (MAR) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marriott International Inc vs Zoetis Inc — how do they compare? Marriott International Inc trades at $365 (market cap $96.76B), while Zoetis Inc trades at $75.53 (market cap $31.95B). The key difference: Marriott International Inc is far larger — about 3× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| MAR | ZTS | |
|---|---|---|
Market Cap | $96.76B | $31.95B |
Sector | Consumer Cyclical | Health |
52-Week High | $402.54 | $156.76 |
52-Week Low | $255.35 | $71.91 |
Enterprise Value | $113.71B | $39.24B |
Dividend Yield | 0.8% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $367.81, up 0.43% on the day, with a bearish technical signal and mixed earnings history. The company reported 2025 revenue of $26.19B and net income of $2.60B, with a P/E of 38.42 and P/B of 443.63 indicating high valuation. Recent news includes strategic partnerships and the upcoming Q2 2026 earnings report on August 3, 2026.
The outlook is cautious due to high valuation and bearish technicals, but analyst consensus suggests a 5.6% upside to the $388.33 price target. Risks include rising debt-to-asset ratio (58.83% in 2025) and competitive pressures, while opportunities lie in travel demand growth and loyalty program strength.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
